Navidea Biopharmaceuticals ROA 2010-2023 | NAVB
Current and historical return on assets (ROA) values for Navidea Biopharmaceuticals (NAVB) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Navidea Biopharmaceuticals ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2023-09-30 | $0.00B | $0.01B | 0.00% |
| 2023-06-30 | $-0.01B | $0.01B | -120.00% |
| 2023-03-31 | $-0.02B | $0.00B | -400.00% |
| 2022-12-31 | $-0.02B | $0.00B | -400.00% |
| 2022-09-30 | $-0.02B | $0.01B | -360.00% |
| 2022-06-30 | $-0.01B | $0.00B | -208.70% |
| 2022-03-31 | $-0.01B | $0.00B | -154.84% |
| 2021-12-31 | $-0.01B | $0.01B | -129.73% |
| 2021-09-30 | $-0.01B | $0.01B | -115.79% |
| 2021-06-30 | $-0.01B | $0.01B | -137.14% |
| 2021-03-31 | $-0.01B | $0.01B | -141.94% |
| 2020-12-31 | $-0.01B | $0.01B | -176.00% |
| 2020-09-30 | $-0.01B | $0.01B | -209.52% |
| 2020-06-30 | $-0.01B | $0.01B | -220.00% |
| 2020-03-31 | $-0.01B | $0.00B | -228.57% |
| 2019-12-31 | $-0.01B | $0.00B | -200.00% |
| 2019-09-30 | $-0.01B | $0.01B | -176.00% |
| 2019-06-30 | $-0.01B | $0.01B | -165.52% |
| 2019-03-31 | $-0.01B | $0.01B | -146.67% |
| 2018-12-31 | $-0.02B | $0.01B | -148.84% |
| 2018-09-30 | $-0.02B | $0.01B | -119.30% |
| 2018-06-30 | $-0.01B | $0.01B | -78.87% |
| 2018-03-31 | $-0.02B | $0.02B | -77.27% |
| 2017-12-31 | $0.08B | $0.02B | 295.15% |
| 2017-09-30 | $0.08B | $0.02B | 323.40% |
| 2017-06-30 | $0.08B | $0.03B | 375.61% |
| 2017-03-31 | $0.08B | $0.03B | 461.54% |
| 2016-12-31 | $-0.02B | $0.01B | -136.36% |
| 2016-09-30 | $-0.01B | $0.01B | -119.15% |
| 2016-06-30 | $-0.02B | $0.01B | -166.04% |
| 2016-03-31 | $-0.03B | $0.01B | -151.52% |
| 2015-12-31 | $-0.03B | $0.02B | -172.31% |
| 2015-09-30 | $-0.03B | $0.02B | -206.45% |
| 2015-06-30 | $-0.03B | $0.02B | -196.83% |
| 2015-03-31 | $-0.03B | $0.01B | -190.77% |
| 2014-12-31 | $-0.04B | $0.01B | -165.52% |
| 2014-09-30 | $-0.04B | $0.02B | -149.57% |
| 2014-06-30 | $-0.05B | $0.02B | -127.89% |
| 2014-03-31 | $-0.05B | $0.03B | -122.08% |
| 2013-12-31 | $-0.04B | $0.04B | -124.44% |
| 2013-09-30 | $-0.04B | $0.05B | -130.84% |
| 2013-06-30 | $-0.03B | $0.03B | -185.92% |
| 2013-03-31 | $-0.03B | $0.01B | -193.33% |
| 2012-12-31 | $-0.03B | $0.01B | -163.38% |
| 2012-09-30 | $-0.03B | $0.01B | -133.33% |
| 2012-06-30 | $0.00B | $0.02B | -3.67% |
| 2012-03-31 | $0.00B | $0.03B | 11.88% |
| 2011-12-31 | $0.01B | $0.03B | 26.67% |
| 2011-09-30 | $0.01B | $0.03B | 68.57% |
| 2011-06-30 | $-0.01B | $0.01B | -90.91% |
| 2011-03-31 | $-0.06B | $0.01B | -590.00% |
| 2010-12-31 | $-0.06B | $0.01B | -662.86% |
| 2010-09-30 | $-0.06B | $0.01B | -678.79% |
| 2010-06-30 | $-0.08B | $0.01B | -902.86% |
| 2010-03-31 | $-0.04B | $0.01B | -491.43% |
| 2009-12-31 | $-0.04B | $0.01B | -445.71% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.000B |
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $180.563B | 21.85 |
| Intuitive Surgical (ISRG) | United States | $177.754B | 73.68 |
| Edwards Lifesciences (EW) | United States | $46.928B | 31.13 |
| IDEXX Laboratories (IDXX) | United States | $45.454B | 52.24 |
| Alcon (ALC) | Switzerland | $45.309B | 30.62 |
| DexCom (DXCM) | United States | $34.894B | 53.93 |
| IQVIA Holdings (IQV) | United States | $33.859B | 19.13 |
| Mettler-Toledo (MTD) | United States | $26.269B | 31.24 |
| STERIS (STE) | Ireland | $22.671B | 24.97 |
| Waters (WAT) | United States | $18.028B | 25.44 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.531B | 0.00 |
| Hologic (HOLX) | United States | $14.819B | 16.10 |
| Sysmex ADR (SSMXY) | Japan | $10.682B | 30.30 |
| Penumbra (PEN) | United States | $9.027B | 70.85 |
| Masimo (MASI) | United States | $8.926B | 32.92 |
| Globus Medical (GMED) | United States | $7.375B | 17.57 |
| Glaukos (GKOS) | United States | $5.388B | 0.00 |
| Teleflex (TFX) | United States | $5.179B | 8.55 |
| Integer Holdings (ITGR) | United States | $3.786B | 18.97 |
| TransMedics (TMDX) | United States | $3.657B | 79.50 |
| PROCEPT BioRobotics (PRCT) | United States | $3.083B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.381B | 14.18 |
| Nihon Kohden (NHNKY) | Japan | $2.144B | 24.59 |
| Elekta AB (EKTAY) | Sweden | $1.991B | 17.90 |
| Veracyte (VCYT) | United States | $1.977B | 27.75 |
| Alphatec Holdings (ATEC) | United States | $1.582B | 0.00 |
| Artivion (AORT) | United States | $1.341B | 125.60 |
| OPKO Health (OPK) | United States | $1.086B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.058B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.019B | 5.42 |
| Pulse Biosciences (PLSE) | United States | $1.004B | 0.00 |
| SiBone (SIBN) | United States | $0.735B | 0.00 |
| IRadimed (IRMD) | United States | $0.716B | 36.33 |
| Beta Bionics (BBNX) | United States | $0.643B | 0.00 |
| AxoGen (AXGN) | United States | $0.609B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.555B | 8.64 |
| OrthoPediatrics (KIDS) | United States | $0.553B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.525B | 11.30 |
| Pacific Biosciences Of California (PACB) | United States | $0.462B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.442B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.416B | 9.67 |
| Delcath Systems (DCTH) | United States | $0.397B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.375B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.358B | 0.00 |
| RxSight (RXST) | United States | $0.324B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.314B | 0.00 |
| Neuronetics (STIM) | United States | $0.297B | 0.00 |
| NeuroPace (NPCE) | United States | $0.295B | 0.00 |
| 908 Devices (MASS) | United States | $0.266B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.245B | 14.86 |
| CVRx (CVRX) | United States | $0.217B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.203B | 0.00 |
| Inogen (INGN) | United States | $0.183B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.180B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.179B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.131B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.120B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.117B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.108B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.108B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.091B | 55.10 |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| Hyperfine (HYPR) | United States | $0.084B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.067B | 0.00 |
| Spectral AI (MDAI) | United States | $0.066B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.053B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.053B | 21.44 |
| EDAP TMS S.A (EDAP) | France | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.018B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.013B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.10 |